Skip to content
Psychedelic Safety Guide
Rule one
Never take a drug you cannot reliably identify.

Part 1 of 4

Before.

Who should take part, in what frame of mind, where, with whom, and how much.

Chapter 01

Participant screening

Many personal factors shape how a psychedelic experience goes. Screening on several criteria helps decide whether it is appropriate at all — and, if it is, how to approach it.

Informed consent & protecting facilitators

Screening protects guides from liability and danger, and helps participants avoid risks and set realistic expectations. Some people come to psychedelics out of desperation, others recreationally; either way, they need to understand the potential effects to give meaningful informed consent.

If you offer yourself as a guide or therapist, set clear boundaries on whom you work with. Guides are often held responsible for psychological harm or physical danger. Being selective lets you work with confidence in the treatment and its outcome.

General screening factors

No single factor guarantees a bad reaction. Mental health, life circumstances and family history should be weighed together. These come up most often:

  • Age: Participants must be legally consenting adults, and young people are advised to avoid psychedelics. The brain keeps developing until about 25; the prefrontal cortex, central to long-term decisions and to pathways of addiction, is among the last parts to mature. MDMA, cannabis and stimulants can affect adolescent development in ways linked to later substance-use problems.
  • Life stability: A session is an inward process; big stressors or plans get in the way of trusting yourself and the experience. Clinical guidance suggests avoiding major life events for several months either side, and major decisions for days or weeks during integration. A stable home is a safe base to come back to.
  • Signs of instability or violence: Any current intention or inclination to harm themselves, others or property is a sign of emotional instability and potentially violent impulses.
  • Self-awareness and accountability: Participants should be able to take responsibility for their actions and reflect on their thoughts and feelings. Someone rigidly attached to their view of reality may struggle; openness and curiosity help.
Physical

Medical risks

Use alongside any of these needs the utmost care:

  • Pregnancy or breastfeeding: don’t take psychedelics.
  • Dementia: people may be unable to give informed consent, and treatment for dementia is little-researched.
  • Epilepsy or other seizures: LSD, MDMA and possibly other psychedelics lower the seizure threshold.
  • Active alcohol withdrawal: raises the risk of seizures.
  • Heart disease or high blood pressure: psychedelics and MDMA act on 5-HT2B receptors, which may raise the risk of heart-valve disease. TripSafe advises against LSD with uncontrolled high blood pressure.
  • Brain injury or stroke: unexpected reactions are more likely; get the neurological risk medically assessed first.
  • MDMA specifically: RollSafe advises avoiding it entirely with heart or blood-vessel disease, uncontrolled high blood pressure, malignant hyperthermia or heat sensitivity, a tendency to seizures, or liver problems.
Psychiatric

Mental health conditions

These carry considerable risk:

  • Psychosis in you or your family: psychedelics may trigger schizoid features or intensify existing symptoms. TripSafe advises against LSD and mushrooms if you, or a first- or second-degree relative, have a current or past psychotic disorder — including schizophrenia and bipolar I or II.
  • Borderline personality disorder, or undiagnosed features of it: instability, desperation and signs of complex PTSD should be addressed through other therapies first, as psychedelics may evoke borderline tendencies.
  • Narcissistic or sociopathic tendencies: psychedelics can boost self-assurance and may feed ego inflation.
Works cited 16 sources
  1. Haden, M., Ball, M., & Woods, B. (2018). Psychedelic Guide Manual. Vancouver, British Columbia.
  2. Johnson, S. B., Blum, R. W., & Giedd, J. N. (2009). Adolescent maturity and the brain: the promise and pitfalls of neuroscience research in adolescent health policy. Journal of Adolescent Health, 45(3), 216–221. doi:10.1016/j.jadohealth.2009.05.016
  3. Schepis, T. S., Adinoff, B., & Rao, U. (2008). Neurobiological processes in adolescent addictive disorders. American Journal on Addictions, 17(1), 6–23. doi:10.1080/10550490701756146
  4. Burish, M. J., Thoren, K. L., Madou, M., Toossi, S., & Shah, M. (2015). Hallucinogens causing seizures? A case report of the synthetic amphetamine 2,5-dimethoxy-4-chloroamphetamine. The Neurohospitalist, 5(1), 32–34. doi:10.1177/1941874414528939
  5. Fisher, D. D., & Ungerleider, J. T. (1967). Grand mal seizures following ingestion of LSD. California Medicine, 106(3), 210–211.
  6. Zagnoni, P. G., & Albano, C. (2002). Psychostimulants and epilepsy. Epilepsia, 43(2), 28–31. doi.org/10.1046/j.1528-1157.2002.043s2028.x
  7. LaPlante, E. (2016). Seized: Temporal Lobe Epilepsy as a Medical, Historical, and Artistic Phenomenon. Open Road Media, pp. 149–150.
  8. Hutcheson, J. D., Setola, V., Roth, B. L., & Merryman, W. D. (2011). Serotonin receptors and heart valve disease – it was meant 2B. Pharmacology & Therapeutics, 132(2), 146–157. doi:10.1016/j.pharmthera.2011.03.008
  9. Droogmans, S., et al. (2007). Possible association between 3,4-methylenedioxymethamphetamine abuse and valvular heart disease. American Journal of Cardiology, 100(9), 1442–1445. doi.org/10.1016/j.amjcard.2007.06.045
  10. Reid, T. E., Kumar, K., & Wang, X. S. (2013). Predictive in silico studies of human 5-hydroxytryptamine receptor subtype 2B (5-HT2B) and valvular heart disease. Current Topics in Medicinal Chemistry, 13(11), 1353–1362. pmc.ncbi.nlm.nih.gov/articles/PMC4086739
  11. Huang, X. P., Setola, V., Yadav, P. N., et al. (2009). Parallel functional activity profiling reveals valvulopathogens are potent 5-hydroxytryptamine(2B) receptor agonists: implications for drug safety assessment. Molecular Pharmacology, 76(4), 710–722. doi:10.1124/mol.109.058057
  12. Cloitre, M., Garvert, D. W., Weiss, B., Carlson, E. B., & Bryant, R. A. (2014). Distinguishing PTSD, complex PTSD, and borderline personality disorder: a latent class analysis. European Journal of Psychotraumatology, 5. doi:10.3402/ejpt.v5.25097
  13. Nour, M. M., Evans, L., Nutt, D., & Carhart-Harris, R. L. (2016). Ego-dissolution and psychedelics: validation of the Ego-Dissolution Inventory (EDI). Frontiers in Human Neuroscience, 10, 269.
  14. TripSafe. LSD side effects. tripsafe.org/lsd-side-effects
  15. TripSafe. Shrooms side effects. tripsafe.org/shrooms-side-effects
  16. RollSafe. How to take MDMA. rollsafe.org/how-to-take-mdma

Chapter 02

Participant mindset

Effects vary so much between people and occasions that “set and setting” is used to predict and steer the course of a trip.

Set

Mindset

The mindset of the person taking the drug.

Setting

Environment

The environment and circumstances around the trip.

Long-term set: temperament & psychology

Your lasting psychology — personality, beliefs, fears and dreams — can surface vividly during a trip.

Someone ready to face their inner self, curious and self-trusting, is more likely to enjoy the strange parts of the experience. Experienced meditators do especially well: they already understand their thought processes and can steer them a little.

People who are rigid, anxious or need control to feel comfortable tend to struggle against the experience. They should prepare thoroughly, build in safety and predictability, and consider a qualified guide — fears can be talked through beforehand and a plan agreed for difficult feelings.

Short-term set: mood & expectations

Go in calm, centred and open — a little nervousness is normal. If you feel unwell or unready on the day, reschedule. Lack of sleep, hunger, illness, worry about real-world problems and extreme moods (depression, mania, anger) all make a difficult trip more likely.

Expectations matter too. Some examples, several from The Psychedelic Experience:

  • expecting pure entertainment or rebellion can leave you unprepared for its strange depth
  • fixating on the medical side of drug effects can lead to worrying you need a doctor
  • fear of being interrupted by family, police or an employer can turn into paranoia
  • a habit of intellectualising can be overwhelmed by the sheer amount of new input

Trying to control a trip by willpower tends to make it more disorienting. Steer it through set and setting instead: a mindful sitter can ease worries, and meditation or relaxation exercises help beforehand.

Chapter 03

Selecting a setting

Prepare as you would for a sleepover at a close friend’s: your favourite clothes, foods and comforts at hand. Largely based on MAPS’s Manual of Psychedelic Support.

Choose a location

If you are inexperienced, pick somewhere familiar, such as your home or a friend’s. Outdoors, choose land or trails you already know. Avoid anywhere you might be interrupted by unexpected guests or authority figures, or seen by neighbours or family. TripSafe adds: no sharp furniture, dangerous objects or windows someone could climb out of — and no responsibilities that day.

Indoors

Maximum control over the space

Tidy up and clear away obstacles and fragile objects. Get each room ready beforehand — playlists, food, bed made, pets fed, art supplies out — so you can relax during the come-up. Draw the blinds, lock the door and unplug from phones and social media.

  • Lighting: soft, indirect light suits dilated pupils — paper lanterns, lava lamps, string lights, LED candles. Avoid real flames; if you must, use tea-lights in deep jars.
  • Comfort: clean surfaces (grime can feel intense), fresh air, plenty of bedding, media ready to play.
  • Clothes: light, comfortable, easy to move in.
  • Safety: put away anything with threatening associations — knives, firearms, toxins or other triggers.
Good indoor activities
  • listening to or playing music
  • looking at or making art
  • yoga and meditation
  • creative or musical games and VR
  • old photos, journals and yearbooks
  • favourite childhood films or nostalgic music
Outdoors

Grounded by nature

Psychedelics often deepen a sense of connection with nature. Bring a guide for outdoor sessions — you are more exposed to interruptions — and plan for natural hazards, with shelter in case of a storm.

  • Lighting: sunglasses — dilated pupils cope badly with bright light.
  • Comfort: a blanket and pillow, and a tent or shelter if you want to be inside.
  • Clothes: comfortable and durable, plus a dry change. Leave precious jewellery at home.
  • Safety: sunscreen, insect repellent, a first-aid kit and plenty of water.
Good outdoor activities
  • watching water, clouds, stars and swaying grass
  • wading in shallow water
  • sitting by a campfire
  • breathing exercises in the fresh air
  • walking pre-planned trails
  • listening to birds, insects, water and leaves

Digital detox

Many people skip phones and tablets during a session — to focus inward, break screen habits or simply avoid conversations. The experience is usually richer when it isn’t spent staring at a screen.

Decorations & visuals

  • projected visuals, or visuals on a spare screen
  • richly patterned tapestries
  • surrealist or visionary art, mandalas, labyrinths, optical illusions
  • flowers, houseplants, crystals and prisms

Food & drink

At the peak most people don’t want to eat. Fresh, simple foods — fruit, vegetables, cheese, bread — stay appealing and are easy to digest during the come-down, when you’ll likely feel tired and hungry. Keep water to hand; honey, lemon and ginger tea helps with dry mouth and nausea.

Incense, smoke & air

Think about how incense, cigarettes or cannabis will affect the air. Some people don’t mind; others find smoke irritating or overwhelming while tripping.

Chapter 04

Guides & sitters

Trip sitting is the psychedelic equivalent of babysitting: while someone is impaired, a sober guide makes sure everything goes well. A guide with specialised training may also act as a therapist.

Picking a guide

Finding the right guide can be hard. Many people ask a close friend with the qualities below; local psychedelic groups can also point to seasoned guides or integration therapists — see Therapists & organisations.

It matters: among people who reported a bad trip, only 2.7% had a trusted, sober and experienced guide with them (TripSafe).

The guide’s role

A guide doesn’t direct the trip. They are a calm, stabilising presence who sets their own impulses aside, encourages the participant to trust, let go and be open, and makes sure the experience happens with a sense of security and trust.

What makes a good psychedelic therapist

  1. Empathic, abiding presence: they understand the participant’s emotional states and trust the process, wherever it leads.
  2. Builds trust in the therapy: their trust in the process carries the participant through bizarre or overwhelming moments.
  3. Spiritual intelligence: comfortable with existential and spiritual ideas and familiar with mystical states.
  4. Knowledge of psychedelics: familiar with their effects and common physical side effects.
  5. Self-awareness and ethical integrity: respects the power dynamics of the relationship, keeps firm boundaries, and understands transference and projection.
  6. Grounding in complementary therapies: such as Holotropic Breathwork, somatic therapies, art and expressive therapy, Internal Family Systems, gestalt therapy and trauma-focused methods like EMDR.
For sitters

Being a trip sitter

  • Before: Get to know each other over several meetings — TripSafe suggests 8+ hours across 4 or more meetings in about a month — and talk through life history, relationships and beliefs. Read up on what to expect together, and agree how you’ll respond if anxiety comes up. Clear the whole duration: roughly 12–16 hours for LSD, 6–9 for mushrooms.
  • During: do: Never leave them alone — a sober sitter present at all times, bathroom trips included. Stay seated, calm and non-directive. About once an hour, gently ask: “Would you like to describe where you find yourself?” Keep pen and paper within reach, your phone silent and the door locked.
  • During: don’t: Don’t over-talk, analyse or dismiss what they say, however unusual. Don’t be abrupt or hide precautions — people on psychedelics pick up unspoken feelings with remarkable accuracy, so look after your own state. Don’t let them leave: use compassionate but firm direction.
  • After: Stay until they are fully back to baseline, leave your contact details for the rest of the day, and meet the next day to talk it through and check they are stable.

Sharing the session

Without a suitable guide, some choose to go alone; then safety protocols, screening and preparation are critical. In some informal practices the guide takes a low dose too — never done in clinical research, and only with informed consent from both.

Touch & boundaries

A hand held out or a hug can be a real comfort, but a guide should ask first. Psychedelics can kindle romantic or confusing feelings, so choose a guide with whom you have strong, established physical boundaries.

Trauma & identity

Participants may project attraction or anger onto the guide; a good guide treats this as emotional processing and stays patient. People working through experiences of race, sexuality, disability or other identity may feel safer with a guide who shares that background.

Works cited 3 sources
  1. Phelps, J. (2017). Developing guidelines and competencies for the training of psychedelic therapists. Journal of Humanistic Psychology, 57(5), 450–487.
  2. Haden, M., Ball, M., & Woods, B. (2018). Psychedelic Guide Manual. Vancouver, British Columbia.
  3. TripSafe. Psychedelic trip sitter guide. tripsafe.org/psychedelic-trip-sitter-guide

Chapter 05

Dosing & testing

Knowing what you’re taking, and how much, is the basis of informed consent. This chapter covers interactions, testing and the doses used in clinical research — for education and harm reduction.

Check first

Interacting medications

  • Never mix MAOIs with MDMA — it can cause dangerous hypertension and serotonin syndrome. RollSafe advises no MAOIs in the three weeks before.
  • SSRIs, SNRIs and MAOIs can all interact with ayahuasca, which itself contains an MAOI (foods and medicines to avoid).
  • Never combine lithium or tricyclic antidepressants with classic psychedelics — they can cause life-threatening seizures or serotonin syndrome.
  • SSRIs and SNRIs blunt LSD, mushrooms and MDMA. Taking more to compensate adds risk — especially for beginners or with a batch of unknown strength.
  • Also avoid with LSD and mushrooms (TripSafe): 5-HTP, St John’s Wort, haloperidol, the HIV medicines ritonavir and indinavir, and cannabis in the 24 hours before.
  • Also avoid with MDMA (RollSafe): St John’s Wort, CYP2D6 inhibitors, anything that raises heart rate or blood pressure (stimulants, some asthma medicines, DXM), sedatives such as alcohol and opioids, and classic psychedelics.

This list isn’t exhaustive. Check every combination before mixing anything.

Visual guide

Combination chart

How LSD, mushrooms and MDMA interact with common substances, from TripSit’s drug combination data. Not every pairing is shown — when in doubt, don’t mix; start low and go slow.

TripSit combination risk for LSD, mushrooms and MDMA with eleven common substances
SubstanceAlcoholCannabisCaffeineCocaineSpeedKetamineBenzosSSRIsMAOIsLithiumTramadol
LSDLow risk & decreaseCautionLow risk, no synergyCautionCautionLow risk & synergyLow risk & decreaseLow risk & decreaseLow risk & synergyDangerousUnsafe
MushroomsLow risk & decreaseCautionLow risk, no synergyCautionCautionLow risk & synergyLow risk & decreaseLow risk & decreaseLow risk & synergyNo TripSit dataUnsafe
MDMACautionLow risk & synergyCautionCautionCautionLow risk & synergyLow risk & decreaseLow risk & decreaseDangerousNo TripSit dataDangerous

Scroll the chart sideways to see every substance.

  • Low risk & synergy
  • Low risk, no synergy
  • Low risk & decrease
  • Caution
  • Unsafe
  • Dangerous
  • No TripSit data

Why the warnings

  • Lithium + LSD (dangerous): high risk of seizures and psychosis reported. TripSit has no rating for lithium with mushrooms or MDMA — other sources advise never combining lithium with classic psychedelics.
  • Tramadol (unsafe with psychedelics, dangerous with MDMA): tramadol lowers the seizure threshold, and psychedelics and stimulants can cause seizures too.
  • MAOIs + MDMA (dangerous): risk of hypertensive crisis and serotonin syndrome. MAOIs also strongly intensify mushrooms and other tryptamines.
  • Cannabis + psychedelics (caution): an unexpectedly strong and unpredictable boost to the trip.
  • Stimulants + psychedelics (caution): amphetamines and cocaine raise anxiety and the risk of thought loops.
  • Alcohol, caffeine, amphetamines or cocaine + MDMA (caution): more strain on the heart and more dehydration; caffeine and amphetamines add to neurotoxicity, alcohol makes it harder to judge how drunk you are, and cocaine blocks MDMA’s effects.
  • SSRIs and benzodiazepines (decrease): they blunt the effects — don’t take more to compensate.
Identify

Know your source & test your supply

Use the most reliable source available, and ask who made it, where it came from and whether anyone has tested it. In the Netherlands you can hand in pills, powders and blotters anonymously at a DIMS test service (run by the Trimbos Institute), and Trimbos Red Alert warns about dangerous pills found on the Dutch market. Measure powders and crystals with a well-calibrated milligram or microgram scale — PsychonautWiki explains why.

For drugs dosed in micrograms, TripSit’s volumetric calculator helps you dissolve a known amount in a known volume of liquid and measure doses from that — label the solution and double-check your maths. Store LSD cool, dark and airtight: wrapped in foil, ideally in the fridge or freezer.

Reagent kits change colour to help identify a tiny sample. Which one you need depends on what you expect to have:

  • LSD: Ehrlich: Genuine LSD turns Ehrlich pink to purple fairly quickly. Fake “acid” often contains NBOMe compounds, which are far more toxic and have caused deaths — never take untested blotter. If the colour is off, follow up with Marquis. Let liquid LSD dry on untreated paper before testing.
  • MDMA: Marquis + Simon’s or Froehde: Marquis tells MDMA apart from cathinones (“bath salts”) and PMA/PMMA; Simon’s rules out MDA, or use Froehde in Europe. Of the “Molly” the DEA analysed between 2009 and 2013, 87% contained no MDMA at all.
  • What reagents can’t tell you: They show what’s present, not purity or strength. Pills can be unevenly mixed, and a positive result doesn’t rule out other substances. For a full lab analysis — including how much MDMA a pill contains — use a DIMS test service.
  • The Dutch market (DIMS, 2025): Ecstasy pills averaged 155 mg MDMA; half held 130–180 mg and 6% more than 210 mg — so one whole pill is usually more than RollSafe’s 120 mg maximum. Blotters averaged 86 µg LSD, and 6% held no LSD but look-alikes such as 1P-LSD or unknown substances.
Read this first
These ranges are not recommendations.
The same dose hits people very differently depending on body weight, neurochemistry, set and setting, and whether a supportive guide is present — and it’s even harder to predict with substances of unknown strength. Start with the lowest active dose and increase only gradually, in later sessions.

Doses used in clinical research

Higher doses bring more risk and more disorienting effects — overwhelming sensations, ego dissolution, projection — which can get in the way of therapy. Studies often start low and add a supplemental dose only if needed.

  • LSD: 100–125 µg orally, with 200 µg considered relatively high. The 250–450 µg doses of 1960s research are no longer studied.
  • Psilocybin: 0.3–0.45 mg/kg of pure psilocybin, studied for anxiety, depression and alcohol dependence. Mushroom potency varies with species and growing conditions.
  • MDMA: 80–125 mg in research on PTSD and on empathy and prosocial behaviour.
Start low, go slow

If you’re going to anyway

TripSafe and RollSafe don’t endorse use outside legal clinical trials. For people who will use regardless, their core advice is the same: start well below a full dose, measure precisely, never redose on impulse.

  • LSD: a first dose of 30–40 µg, raised only on later, separate occasions. Starting small is linked to more lasting benefit.
  • Mushrooms: about 0.8 g dried to start. Identify them with great care — the main physical danger is a poisonous look-alike. In the Netherlands, psilocybin truffles are sold legally in smartshops; they avoid that risk but are dosed differently from dried mushrooms, so follow the shop’s guidance and start low.
  • MDMA: 80 mg or less the first time and never more than 120 mg in a session, even for heavier people. Avoid boosters. Dutch pills average 155 mg, so test first and take only part of one.

How long to wait between sessions: see Moderate use.

Works cited 26 sources
  1. TripSit. Drug combinations. wiki.tripsit.me/wiki/Drug_combinations
  2. Nour, M. M., Evans, L., Nutt, D., & Carhart-Harris, R. L. (2016). Ego-dissolution and psychedelics: validation of the Ego-Dissolution Inventory (EDI). Frontiers in Human Neuroscience, 10, 269.
  3. Phelps, J. (2017). Developing guidelines and competencies for the training of psychedelic therapists. Journal of Humanistic Psychology, 57(5), 450–487.
  4. Strassman, R. (2017, 5 October). The political correction of psychedelics, part 4: manageable doses. rickstrassman.com
  5. Leary, T., Metzner, R., & Alpert, R. (1964). The Psychedelic Experience: A Manual Based on the Tibetan Book of the Dead. New York: University Books.
  6. Oehen, P., Traber, R., Widmer, V., & Schnyder, U. (2013). A randomized, controlled pilot study of MDMA-assisted psychotherapy for treatment of resistant, chronic post-traumatic stress disorder (PTSD). Journal of Psychopharmacology, 27(1), 40–52.
  7. Carhart-Harris, R. L., Bolstridge, M., Rucker, J., et al. (2016). Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. The Lancet Psychiatry, 3(7), 619–627.
  8. Liechti, M. E. (2017). Modern clinical research on LSD. Neuropsychopharmacology, 42(11), 2114.
  9. Carhart-Harris, R. L., Kaelen, M., Whalley, M. G., et al. (2015). LSD enhances suggestibility in healthy volunteers. Psychopharmacology, 232(4), 785–794.
  10. Krebs, T. S., & Johansen, P. Ø. (2012). Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials. Journal of Psychopharmacology, 26(7), 994–1002.
  11. Ross, S., Bossis, A., Guss, J., et al. (2016). Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. Journal of Psychopharmacology, 30(12), 1165–1180.
  12. Bogenschutz, M. P., Forcehimes, A. A., Pommy, J. A., et al. (2015). Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study. Journal of Psychopharmacology, 29(3), 289–299.
  13. Stamets, P., & Fanaticus, P. (1997). Excerpts from “Psilocybin Mushrooms of the World” – Dosage: how many mushrooms to ingest? Psylocybe Fanaticus.
  14. Mithoefer, M. C., Wagner, M. T., Mithoefer, A. T., Jerome, L., & Doblin, R. (2011). The safety and efficacy of MDMA-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study. Journal of Psychopharmacology, 25(4), 439–452.
  15. Hysek, C. M., Schmid, Y., Simmler, L. D., et al. (2013). MDMA enhances emotional empathy and prosocial behavior. Social Cognitive and Affective Neuroscience, 9(11), 1645–1652.
  16. Shulgin, A., & Shulgin, A. (1991). PIHKAL: A Chemical Love Story. erowid.org
  17. TripSafe. How to take LSD. tripsafe.org/how-to-take-lsd
  18. TripSafe. How to take shrooms. tripsafe.org/how-to-take-shrooms
  19. TripSafe. LSD test kits. tripsafe.org/lsd-test-kits
  20. RollSafe. MDMA test kits. rollsafe.org/mdma-test-kits
  21. RollSafe. MDMA dosage. rollsafe.org/mdma-dosage
  22. RollSafe. How to take MDMA. rollsafe.org/how-to-take-mdma
  23. TripSit. Drug combinations chart. tripsit.me/combo
  24. TripSit Wiki. Drug combinations. wiki.tripsit.me/wiki/Drug_combinations
  25. TripSit. Volumetric dosing calculator. volume.tripsit.me
  26. Trimbos Institute. (2026). DIMS Annual Report 2025. trimbos.nl

Part 2 of 4

During.

What to set up before you start, how to help when it gets hard, and the stages you’ll move through.

Chapter 06

Safety protocols

A trip should be as predictable as possible, with no interruptions or obligations. Plan it as a two-day experience.

Plan ahead

The two-day plan

  • wait until you’ve felt emotionally steady for a few weeks
  • sleep 8+ hours the night before and the night after
  • keep the whole next day free
  • skip cannabis for 24 hours beforehand
  • eat a light, healthy meal 1–2 hours before — a full stomach delays the onset, and nausea is common
  • hand your phone to your sitter
  • don’t drive while any effects remain
  • no major decisions for 1–2 days afterwards
Write it down

Your boundaries

Psychedelics impair working memory, so people sometimes do risky things without noticing. Write a list beforehand and adapt it to your own vulnerabilities:

  • don’t redose or take anything unplanned
  • don’t handle sharp objects or fire
  • if you get hurt, calmly get first aid
  • don’t send messages, make calls or answer the door
  • if help is needed, a sober person makes the call
  • you are not dying — feelings of death and rebirth are safe and pass
  • no driving or machinery, no deadlines or chores

To help yourself remember: hide sharp objects, put a “stay inside” note on the front door, switch your phone off — or write a reminder on your hand.

On the back of your hand
“You have taken a mind-altering drug. This is a temporary state.”
When it gets hard

Helping someone through a bad trip

  1. Mild anxiety: offer steady support and reassurance.
  2. Rising anxiety: stay calm while acknowledging how intense it feels. Don’t try to “talk them down” to reality — that can make it worse. Encourage them to go with the experience rather than fight it.
  3. Ground them: with their consent, a hand on the arm or shoulder, or holding hands. Remind them they took a hallucinogen and will return to normal soon.
  4. Get help when needed: if reassurance isn’t working, they might hurt themselves or others, or there are physical warning signs, a sober person calls 112 (the emergency number in the Netherlands and across the EU) and tells responders what was taken.
What to say and do
  • Ask, then listen: Find out what they took, how much and when. Let them lead the conversation — one calm helper is better than a crowd.
  • Breathe together: Eyes closed, slow deep breaths, focusing only on the breath for about 30 seconds. Panic attacks feel awful, but they are not dangerous.
  • Change the scene: Different music, softer light, another room, a glass of water.
  • Gentle distraction: Talk about things they love, or draw, listen to music or put on something calm to watch.
  • Choose your words: Say “stay calm”, not “don’t panic”, and don’t sound surprised at how long it’s lasting.
MDMA

Heat & water

A standard dose of MDMA raises body temperature by about a degree and disrupts the body’s cooling — heatstroke can happen even indoors. Avoid hot, crowded places and take regular cooling breaks. MDMA also makes you feel thirstier than you are while the body holds on to water, so too much plain water can be fatal.

Sip, don’t chug: about 250 ml an hour, up to 500 ml if dancing or in the heat — ideally an electrolyte or sports drink.

  • Heat exhaustion: Heavy sweating, weakness, cold and clammy skin, a fast weak pulse, nausea, fainting. Move somewhere cool, lie down, use cool wet cloths.
  • Water poisoning (hyponatremia): Nausea, vomiting, headache, confusion and fatigue after drinking a lot of water. It can be fatal — get medical help.

Heatstroke is an emergency

Hot red skin, a fast strong pulse, very high temperature, seizures or unconsciousness. Call 112, move them somewhere cool and cool them with wet cloths. No drinks if they are confused or unconscious.

Works cited 5 sources
  1. TripSafe. How to take LSD. tripsafe.org/how-to-take-lsd
  2. TripSafe. How to help someone having a bad trip on LSD/shrooms. tripsafe.org
  3. RollSafe. How to take MDMA. rollsafe.org/how-to-take-mdma
  4. RollSafe. MDMA side effects. rollsafe.org/mdma-side-effects
  5. TripSit Wiki. How to tripsit online. wiki.tripsit.me

Chapter 07

What to expect

A psychedelic experience has three stages. Their timing depends on the drug and how it was taken.

01

Onset

The “come-up”: bodily and mental symptoms as the effects set in.

02

Peak

An extended period of peak intensity.

03

Come-down

Effects taper and plateau — the longest stretch.

Timeline

How long it lasts

Typical timelines when swallowed, from TripSit. Higher doses last longer, so clear the whole day.

LSD Comes up in 30–120 min · 8–12 h in total · you may feel “off” the next day
Mushrooms Comes up in 15–60 min · peak 2–4 h · 4–8 h in total · an afterglow is common
MDMA Comes up in 20–70 min · 3–5 h in total · after-effects for 2–24 h
  • Come-up
  • Main effects
  • After-effects

In the body

  • LSD in the body: Dilated pupils, light sensitivity, slightly raised heart rate, blood pressure and temperature, sweating; nausea is uncommon at lower doses. Physically it is very hard to overdose on, though rare cases of dangerous overheating have been reported.
  • Mushrooms in the body: Nausea and stomach upset, dizziness, sleepiness, dilated pupils, raised heart rate and blood pressure. Headaches can last up to a day; a hangover is rare.
  • MDMA in the body: During: dry mouth, jaw clenching, no appetite, eye wiggles, dizziness, restless legs, overheating. Afterwards: fatigue, poor sleep, low mood and trouble concentrating — mostly gone within 3–4 days.

The come-up

Make final preparations — playlists (screens get confusing), blankets, food, comfortable clothes. Common symptoms:

  • clamminess, or narrowing of blood vessels
  • nausea and a churning stomach
  • vomiting, especially with ayahuasca, peyote and LSA, and sometimes mushrooms
  • anxiety until the main effects arrive
  • minor tremors or electric sensations

These are expected: stay comfortable and simply notice them.

Intent & letting go

Many people set an intent — not an expectation, but a reassurance that the journey will be meaningful:

  • I am ready to grow into a happier person
  • I am ready to love myself
  • The past cannot limit me
  • Growing is exciting, even through pain
  • When one door closes, another opens

For a deeper, ego-transforming session, let the experience flow:

  • let go of expectations, worries, social drama and attachments
  • notice new effects without fixating on them
  • let identity and beliefs rest; simply exist as you are
  • allow changes in time and your surroundings

The peak

In therapy sessions people often spend the peak lying down with a blindfold or headphones, guided by a sitter, spoken word or chosen music. At medium to high doses you may:

  • feel engulfed by light, your ego dissolving
  • seem to travel inward to a cellular level
  • meet gods or unfamiliar entities
  • feel death and rebirth, or glimpse “past lives”
  • feel time is arbitrary or continuous
  • feel one with the universe, or with another person
  • feel like a blank slate, as if waking from a dream
  • have your sense of identity replaced by other associations
Whatever happens
These states are temporary, and you will return.
Treat what you experience as lessons that, once integrated, can help reshape patterns of thought and behaviour. No two peaks are alike.

Come-down & plateau

After the peak, effects taper and level off. Visuals may continue for hours with less body load — the longest part of the trip, and a good time for art, nature, a film or talking with your sitter. In a safe, caring environment, this is when body and mind reorganise.

Works cited 5 sources
  1. TripSit Wiki. LSD. wiki.tripsit.me/wiki/LSD
  2. TripSit Wiki. Mushrooms. wiki.tripsit.me/wiki/Mushrooms
  3. TripSit Wiki. MDMA. wiki.tripsit.me/wiki/MDMA
  4. TripSafe. LSD side effects. tripsafe.org/lsd-side-effects
  5. RollSafe. MDMA side effects. rollsafe.org/mdma-side-effects

Part 3 of 4

After.

Making sense of the experience, keeping use moderate, and effects that linger.

Chapter 08

Integrating experiences

Integration means coming to terms — emotionally, mentally and physically — with what happened, and carrying something useful from it into daily life.

After a good trip

Integration is usually straightforward: making sense of what happened and managing expectations about what it brought up. Journalling, talking it through with your sitter and resting all help.

After a hard trip

Strange, overwhelming or traumatic trips more often need integration therapy — help making sense of events, memories, visions or psychotic episodes. Many therapy approaches work; the focus is on reframing associations with what was traumatic. Guides trained in trauma therapy can help — the ICEERS Support Center offers free online sessions, or see Therapists & organisations.

Chapter 09

Moderate use

To reduce risk, keep use moderate and watch for long-term effects. Keep a log of dates, substances, doses and experiences — with journal entries, drawings and diagrams.

Rest & recover

Space it out

  • Between sessions: wait until the last experience feels fully integrated — TripSafe suggests at least a month for psychedelics. For MDMA, RollSafe suggests at least 3–5 weeks, ideally around three months.
  • Rest: sleep 8+ hours the night after and take the next day off.
  • MDMA supplements: RollSafe lists antioxidants such as alpha-lipoic acid, acetyl-L-carnitine and vitamin C, but the evidence is mostly from animal studies. Never take 5-HTP within 24 hours of MDMA. Supplements and testing don’t guarantee safety.
Check in

When it starts to weigh on you

With regular use, it’s not unusual to feel caught in a double bind: the experiences feel healing, but symptoms or life disruptions slowly build up. That’s the moment to stop, step back and take stock of each area of life below.

  • Emotional well-being: Aim for steady contentment: openness, patience, belonging, kindness to others and acceptance of yourself.
  • Relationships: Watch for changes with family and old friends. Stay close to people who have your best interests at heart; be wary of strangers who encourage recklessness.
  • Responsibilities: Notice changes at work or school, and make sure you can support yourself and anyone who depends on you.
  • Mental health: Scrambled or obsessive thoughts, more dissociation, jumpiness or lingering hallucinations are signs to slow down — and that integration therapy could help.
  • Physical health: Watch appetite, energy, muscle tension and stomach trouble. Eat well, move, and look after your body.

Built on Maslow’s hierarchy of needs

These areas follow Maslow’s hierarchy of needs and principles from dialectical behaviour therapy.

  • Self-actualisationmorality, creativity, spontaneity, problem solving
  • Esteemself-esteem, confidence, achievement, respect
  • Love & belongingfriendship, family, intimacy
  • Safetysecurity of body, work, resources, family, health and property
  • Physiologicalbreathing, food, water, sleep, homeostasis
Works cited 5 sources
  1. Maslow, A. H. (1943). A theory of human motivation. Psychological Review, 50(4), 370.
  2. Reutter, K. (2019). The Dialectical Behavior Therapy Skills Workbook for PTSD. New Harbinger Publications, pp. 34–36.
  3. TripSafe. How to take shrooms. tripsafe.org/how-to-take-shrooms
  4. RollSafe. How to take MDMA. rollsafe.org/how-to-take-mdma
  5. RollSafe. MDMA supplements. rollsafe.org/mdma-supplements

Chapter 10

Persisting effects

Some effects outlast the drug — more likely with a poor set and setting, frequent use or high doses. Whatever you’re dealing with, keep social and medical support in place. Cognitive behavioural therapy (CBT), dialectical behaviour therapy (DBT), art therapy and an experienced psychedelic therapist can all help.

Most common

Hallucinogen persisting perception disorder (HPPD)

HPPD means re-experiencing psychedelic effects in daily life — brief visual disturbances, perceptual changes, emotional shifts — sometimes described as flashbacks. Research separates passing, harmless effects (type I) from long-lasting, distressing ones (type II). Estimates of how common it is range from 0.12% to 4.1% (TripSafe), and it appears more often after illicit use than in research settings.

  • heightened sensory and bodily sensations
  • colour confusion, flashes of colour
  • trouble reading because of visual disturbances
  • geometric patterns, eyes open or closed
  • visual snow or static
  • halos or auras around objects
  • illusions of movement at the edge of vision
  • trails or afterimages behind moving objects
  • more visible floaters
  • seeing faces and patterns in things
  • misjudging the size of objects
  • hallucinations when falling asleep or waking

Mild HPPD can feel harmless or even pleasant, and often fades with sobriety, emotional stability and self-care. Stronger forms can be intrusive and may need therapeutic or medical support. Cannabis, dim lighting and reminders of a past trip can trigger it. Sunglasses reduce visual intensity; CBT, psychotherapy and psychiatric medication may also help.

Re-experiencing trauma

Psychedelics increase connectivity between brain regions, which can surface suppressed memories or traumatic images. A guide should encourage trust in the participant’s inner resources; integration therapy helps turn this into something constructive.

Under the influence, false memories can arise, or ordinary ones can take on a traumatic colour. Weigh recovered memories against the wider story of your life before revising it.

Habitual escapism

Because altered states are so novel, some people come to depend on psychedelics for cognitive, aesthetic or spiritual highs — often because of hard circumstances or mental illness, which also raise the risks. Neglecting responsibilities or safety for psychedelic states is a sign of problem use. Beyond this, psychedelics carry a low risk of dependence.

Delirious or obsessive thinking

Psychedelics can also bring confused or obsessive thought patterns — from a vulnerability missed in screening, or a difficult trip. Integration and complementary therapies help organise confusing memories. Some people feel a strong urge to write, draw or perform; creativity can be a valuable part of their integration.

Dissociation

Some people experience dissociation, depersonalisation or derealisation, often rooted in trauma or neurodevelopment and intensified by psychedelics. Complementary practices focused on reducing dissociation are recommended.

Stronger spiritual or metaphysical beliefs

  • Coincidences & synchronicities: Noticing more coincidences, number and word associations, or thoughts that seem to predict music, conversations or events.
  • Telepathy & psychic abilities: Telepathic experiences are often reported in group sessions, and some people come away believing they have psychic powers. These remain unproven; watch for delusional thinking.
  • Unity, non-duality: A sense of one consciousness underlying all life, shared by many traditions — felt as ego loss, dissociation or deeper empathy.
  • Autonomous beings: Belief in spiritual or otherworldly entities. Because these experiences are so intense, explore them with a supportive therapist or mentor who can help you avoid confused beliefs.

Changes to sexuality or gender identity

Psychedelics may heighten or dampen sexual interest, or raise questions about orientation, gender identity and presentation. Don’t rush into risky experiences or conclusions — lasting change usually reflects lifelong feelings that psychedelics bring to your attention. Confide in a friend, therapist or support group where you feel understood and safe, and avoid any group that pushes drug use during sex.

Works cited 26 sources
  1. Reed, G. (2019, August). Psychedelic therapy. Effect Index.
  2. Pifalo, T. (2007). Jogging the cogs: trauma-focused art therapy and cognitive behavioral therapy with sexually abused children. Art Therapy, 24(4), 170–175. archive.org/details/ERIC_EJ791441
  3. Chapman, L., Morabito, D., Ladakakos, C., Schreier, H., & Knudson, M. (2001). The effectiveness of art therapy interventions in reducing post traumatic stress disorder (PTSD) symptoms in pediatric trauma patients. Art Therapy, 18(2), 100–104. doi.org/10.1080/07421656.2001.10129750
  4. Schouten, K. A., de Niet, G. J., Knipscheer, J. W., Kleber, R. J., & Hutschemaekers, G. J. M. (2015). The effectiveness of art therapy in the treatment of traumatized adults. Trauma, Violence, & Abuse, 16(2), 220–228. doi.org/10.1177/1524838014555032
  5. Elkins, C., & Rosenberg, J. (2019, 13 July). Hallucinogen persisting perception disorder (HPPD). DrugRehab.com. drugrehab.com
  6. Abraham, H. D., & Wolf, E. (1988). Visual function in past users of LSD: psychophysical findings. Journal of Abnormal Psychology, 97(4), 443.
  7. Abraham, H. D. (1983). Visual phenomenology of the LSD flashback. Archives of General Psychiatry, 40(8), 884–889.
  8. Hermle, L., Simon, M., Ruchsow, M., & Geppert, M. (2012). Hallucinogen-persisting perception disorder. Therapeutic Advances in Psychopharmacology, 2(5), 199–205. doi:10.1177/2045125312451270
  9. Orsolini, L., Papanti, G. D., De Berardis, D., et al. (2017). The “endless trip” among the NPS users: psychopathology and psychopharmacology in the hallucinogen-persisting perception disorder. A systematic review. Frontiers in Psychiatry, 8, 240.
  10. PsychonautWiki. Hallucinogen persisting perception disorder. psychonautwiki.org
  11. Lerner, A. G., Rudinski, D., & Bor, O. (2014). Flashbacks and HPPD: a clinical-oriented concise review. Israel Journal of Psychiatry and Related Sciences, 51(4), 296.
  12. Martinotti, G., Santacroce, R., Pettorruso, M., et al. (2018). Hallucinogen persisting perception disorder: etiology, clinical features, and therapeutic perspectives. Brain Sciences, 8(3), 47.
  13. Halpern, J. H., & Pope Jr, H. G. (2003). Hallucinogen persisting perception disorder: what do we know after 50 years? Drug and Alcohol Dependence, 69(2), 109–119.
  14. Carhart-Harris, R. L., Leech, R., Hellyer, P. J., et al. (2014). The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs. Frontiers in Human Neuroscience, 8, 20.
  15. Gidron, Y., Peri, T., Connolly, J. F., & Shalev, A. Y. (1996). Written disclosure in posttraumatic stress disorder: is it beneficial for the patient? Journal of Nervous and Mental Disease, 184(8), 505–507. doi.org/10.1097/00005053-199608000-00009
  16. American Psychological Association. (2019). Memories of childhood abuse. apa.org/topics/trauma/memories
  17. Goldberg, L. A psychoanalytical look at recovered memories. Cultic Studies Review, 2(3), 256–264. icsahome.com
  18. Johnson, M. W., Richards, W. A., & Griffiths, R. R. (2008). Human hallucinogen research: guidelines for safety. Journal of Psychopharmacology, 22(6), 603–620.
  19. LaPlante, E. (2016). Seized: Temporal Lobe Epilepsy as a Medical, Historical, and Artistic Phenomenon, pp. 246–248. Open Road Media. play.google.com
  20. Grof, S. (1980). LSD Psychotherapy. Hunter House, Pomona CA, p. 272.
  21. Luke, D. (2012). Psychoactive substances and paranormal phenomena: a comprehensive review. International Journal of Transpersonal Studies, 31(1), 97–156. doi.org/10.24972/ijts.2012.31.1.97
  22. Luke, D. (2011). Discarnate entities and dimethyltryptamine (DMT): psychopharmacology, phenomenology, and ontology. Journal of the Society for Psychical Research, 75(902).
  23. McGreal, S. (2012). DMT, aliens, and reality. Psychology Today. Part 1 and part 2
  24. Metzner, R. (1998). Hallucinogenic drugs and plants in psychotherapy and shamanism. Journal of Psychoactive Drugs, 30(4), 333–341. doi.org/10.1080/02791072.1998.10399709
  25. TripSafe. LSD side effects. tripsafe.org/lsd-side-effects
  26. TripSafe. Shrooms side effects. tripsafe.org/shrooms-side-effects

Part 4 of 4

Together.

Finding good practitioners and groups — and recognising the bad ones.

Chapter 11

Therapists & organisations

The practitioners and organisations below have not been vetted by this guide. Check the credibility of any facilitator or group — see Abusive practitioners.

Finding a practitioner

Before any therapy event or retreat — including the legal truffle ceremonies offered in the Netherlands — check the host’s reputation with former participants and the wider community.

Clinical research trials

Search for psychedelic studies running in the Netherlands and the rest of the EU.

What a good group offers

  • friends who share your interests in consciousness, science and spirituality
  • shared reading on psychedelic research and therapy
  • learning harm reduction and planning safe sessions together
  • talking through experiences and learning from each other’s mistakes

Know what a group is — and isn’t

A psychedelic group is not a clinical setting or an experienced retreat centre. Groups often also serve unadvertised purposes — exchanging drug sources, or finding people to trip with. Research any group with care.

Works cited 1 source
  1. Psychedelics Today. (2018, 24 October). Statement on MycoMeditations.

Chapter 12

Abusive practitioners

Harm reduction means naming abuse. This chapter covers abusive behaviour that sometimes appears in therapy and retreat settings, practised or tolerated by facilitators.

Why psychedelics raise the stakes

Psychedelics can rapidly deepen intimacy and dependence and weaken informed consent. Facilitators must make sure participants feel physically and psychologically safe, because participants may experience:

  • a deep feeling of connection to others
  • heightened suggestibility
  • dissociation and ego loss
  • a sense of special personal significance
  • traumatic memories resurfacing
  • transferred trust or sexual interest that wouldn’t otherwise be there
  • paranoia, especially around illegal activity
  • worsening mental illness and growing reliance on others
Warning signs

Recognising problematic practices

  • No accountability: Facilitators answer to no medical or therapy organisation, or have no formal training and certification.
  • Risky or addictive drugs: Facilitators openly offer non-psychedelic drugs that can destabilise participants.
  • Crossed boundaries: Physical, emotional, chemical, social or sexual. Nobody should be attacked, belittled, dosed without consent, harassed or molested.
  • Sex with people under the influence: Condoning sex on mind-altering drugs, or using drugs as “tools of seduction”. Nobody under the influence can give informed consent; women and other vulnerable people are most at risk.

Psychedelics can rearrange one’s sense of self and increase susceptibility to influence, so personal autonomy is critical. Good facilitators also protect participants from other participants: vulnerable people attract bad actors, and competent facilitators notice and step in.

Protect yourself

Staying safe

  1. Choose a reputable setting. Work with an experienced clinician or therapist recommended by respected researchers or publications. Research retreats and healers online and speak to former participants. Go with friends — abuse is more common when people go alone — and with facilitators you feel safe with, especially if you are a woman or marginalised.
  2. Avoid groups that enable drug abuse. Steer clear of groups encouraging frequent use; look for ones involved in harm reduction, research or complementary therapy.
  3. Protect your boundaries. You never owe anyone physical or verbal contact. If someone wants to take you away from the group, say no or bring a trusted companion. Planned touch in somatic or shamanic practice should never involve intimate areas, and you can always object.
  4. Watch for a guide with sexual intentions. Comments on your looks, being overly “touchy”, talk of romance, pacts of secrecy, “love magic”, stressing sex-enhancing effects, or treating you as special or chosen are warning signs. Sex between guide and participant is never appropriate. Attraction to a guide is common and may be part of the healing context — revisit it sober, if at all. You should never be required to undress fully; bring swimwear for rituals such as herbal baths.
  5. Be aware of cultural differences. Misogyny is widespread in many places. Misreading never justifies abuse, but knowing local signals and dress customs helps; some retreats ask that revealing clothing not be worn.
  6. Talk to someone. On the spot or later, tell family, trusted friends or established community members who have your best interests at heart.

Recovering from abuse

Abuse during a session can cause lasting distress, and victims often struggle to be heard. It is never the victim’s fault — it usually happens because of irresponsible facilitators.

If you were abused, harassed or manipulated, you may feel unstable, dissociated or uncertain. An integration therapist can help you make sense of it, as can trauma-focused approaches such as DBT and radically open DBT, somatic and movement therapies, and therapeutic massage.

Works cited 11 sources
  1. Carhart-Harris, R. L., Erritzoe, D., Haijen, E., Kaelen, M., & Watts, R. (2018). Psychedelics and connectedness. Psychopharmacology, 235(2), 547–550.
  2. Carhart-Harris, R. L., Kaelen, M., Whalley, M. G., et al. (2015). LSD enhances suggestibility in healthy volunteers. Psychopharmacology, 232(4), 785–794.
  3. Preller, K. H., Schilbach, L., Duerler, P., Pokorny, T., & Vollenweider, F. X. (2019). LSD increases social adaptation to opinions similar to one’s own. European Neuropsychopharmacology, S226–S227. bibliography.maps.org
  4. Nour, M. M., Evans, L., Nutt, D., & Carhart-Harris, R. L. (2016). Ego-dissolution and psychedelics: validation of the Ego-Dissolution Inventory (EDI). Frontiers in Human Neuroscience, 10, 269.
  5. Griffiths, R. R., Richards, W. A., McCann, U., & Jesse, R. (2006). Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology, 187(3), 268–283.
  6. Griffiths, R. R., Johnson, M. W., Richards, W. A., et al. (2011). Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects. Psychopharmacology, 218(4), 649–665.
  7. Phelps, J. (2017). Developing guidelines and competencies for the training of psychedelic therapists. Journal of Humanistic Psychology, 57(5), 450–487.
  8. Chacruna Institute. (2018, 19 November). Ayahuasca community guide for the awareness of sexual abuse.
  9. Sinclair, E. (2019, 24 April). Confronting sexual misconduct in the psychedelic community: an interview with Daniel Pinchbeck. Chacruna. chacruna.net
  10. Caicedo Fernández, A. (2018). Power and legitimacy in the reconfiguration of the yagecero field in Colombia. In B. C. Labate & C. Cavnar (Eds.), The Expanding World Ayahuasca Diaspora (pp. 199–216). researchgate.net
  11. Peluso, D. (2018, 5 October). Ayahuasca’s attractions and distractions: examining sexual seduction in shaman-participant interactions. Chacruna.

Chapter 13

Problematic groups

Issues seen in recreational groups, psychedelic organisations and groups with hierarchical power structures. A group that suits one person may overwhelm another — find one that feels right for you.

Medical settings aren’t recreational ones

If you want therapeutic benefit, look to medical resources, not recreational groups. Casual users often prioritise the high over lasting well-being, while clinical settings offer far more psychological support and safety planning.

Recreational use can still be meaningful, but psychedelics deserve respect as powerful medicines. People seeking healing in a party setting can end up overwhelmed or vulnerable, and others there may not notice someone struggling or being mistreated.

Psychedelic tribalism

Psychedelics have a history with intentional communities, initiation rituals and cults, and groups that bond through regular sessions can mirror their effects: intense bonds, ideology, volatility. Take this seriously.

Some privacy is legitimate. Groups may protect members who are mentally ill or neurodiverse, trauma survivors, minorities, LGBTQ people or those coming out — and professionals who need anonymity for their careers.

Red flags

Abusive & cultic behaviour

Not every item is abuse in itself, but each can signal comfort with escalating illegal activity, dependence, abuse or sexual coercion:

  • promoting risky non-psychedelic drugs, physical abuse, sexual or romantic manipulation, harassment or stalking
  • charismatic leaders who treat their own beliefs as beyond question
  • secrecy around illicit dealings — selling drugs, sharing sources, pushing high-risk drugs
  • vilifying ex-members and anyone close to them, punishing critics, or threatening blackmail
  • heavy ideological, political or religious pressure, with fear, misinformation and easy expulsion
  • trading sexual favours, pressuring people about their sexuality, or using it to shame or punish
  • dosing people without their knowledge, lying about what they’re taking, or pressuring them to use more — especially when already intoxicated

Red flags online

  • deleting or editing logs and messages to change the record
  • not screening for people at high psychological or medical risk, or with a history of abuse
  • not screening for minors, or older members grooming younger ones
  • private side groups for drugs or sex; collecting explicit images that could be used for extortion
  • meetups centred on drugs or sex rather than the group’s stated purpose
  • encouraging risky drug use, or mocking people who ask for help
  • advertising drug sources through encrypted, self-destructing hosts
Green flags

Signs of a safe group

  • members respect each other’s emotional, physical and sexual boundaries
  • organisers admit mistakes and accept criticism
  • critical thinking, self-respect and autonomy are valued
  • contact with family and existing friends is encouraged
  • the organisation is open about its structure, history and finances
  • ex-members aren’t vilified or shunned
  • online: clear data policies, meetups about support or research, and no tolerance for illegal activity

Gaslighting & manipulation

Gaslighting hides abuse by making victims doubt their own experience. On psychedelics it can be deeply traumatising while going unnoticed by others. It isn’t always deliberate — it can become someone’s unconscious habit, which they then deny.

How it’s done
  • dismissing what the victim says
  • belittling their worth
  • withholding information
  • verbal abuse, including “jokes”
  • cutting them off socially
How it can feel
  • constantly second-guessing yourself
  • always apologising, feeling you can’t do anything right
  • lying or hiding things to avoid being put down
  • anxious about raising harmless topics
  • friends or family trying to protect you from the group
  • sudden anger at people you used to get along with
Rebuilding

Recovering from manipulation

Having abuse denied is traumatic in itself. A trauma specialist or integration therapist who understands gaslighting in psychedelic settings can help you rebuild a sense of safety and trust:

  • Cease contact: Remove the abusers or group from your life completely.
  • Call it what it is: Acknowledge that you were abused, and by whom, without needing to make sense of everything.
  • Feel your feelings: Let whatever comes up come out.
  • Get help: A trauma specialist, integration therapist, family member, trusted friend or spiritual guide.
  • Don’t retaliate: Revenge keeps you attached and usually backfires.
  • Move on: Build relationships with people who respect you, and make choices that empower you.
  • Learn the signs: Read up on gaslighting and emotional abuse so you can spot them in future.
  • Be patient with yourself: Fear may linger for a while. Give yourself the compassion your abusers didn’t — things do improve.
Works cited 18 sources
  1. Doblin, R. (2015, 4 March). Psychedelic healing with marijuana, MDMA, psilocybin, & ayahuasca. Bulletproof, YouTube. youtu.be/MEk_4wwvSLE
  2. Mayorga, O., & Smith, P. (2019). Forgiving psychedelic abusers should never be at the expense of their victims. Psymposia. psymposia.com
  3. Douglas, J. (2017). Inside the bizarre 1960s cult, The Family: LSD, yoga and UFOs. The Guardian. theguardian.com
  4. Windolf, J. (2007). Sex, drugs, and soybeans. Vanity Fair. vanityfair.com
  5. Neiswender, M. (1971). Manson girl’s acid trips detailed. CieloDrive.com. cielodrive.com
  6. Bieberman, L. (1967, 5 August). The psychedelic experience. The New Republic. luminist.org
  7. Rosedale, H. (2015). On using the term “cult”. ICSA Today, 6(3), 4–6. icsahome.com
  8. Langone, M. D. (2015). Characteristics associated with cultic groups. International Cultic Studies Association. icsahome.com
  9. NSPCC. (2019). Child sexual exploitation. nspcc.org.uk
  10. Wolak, J., Finkelhor, D., Mitchell, K. J., & Ybarra, M. L. (2008). Online “predators” and their victims. American Psychologist, 63, 111–128. apa.org
  11. NSPCC. (2019). Grooming. nspcc.org.uk
  12. Federal Bureau of Investigation. (2019, 30 May). Dangerous connections: youth face a risk of sextortion online. fbi.gov
  13. Evans, P. (1996). The Verbally Abusive Relationship (2nd ed.). Holbrook, MA: Adams Media.
  14. Shearman, S. (2017, 30 March). Cyberbullying in the workplace: “I became paranoid.” The Guardian. theguardian.com
  15. Stern, R. (2007). The Gaslight Effect. New York: Morgan Road Books.
  16. Johnson, M. Z. (2016). 6 unexpected ways I’ve healed from gaslighting abuse and learned to trust myself again. Everyday Feminism. everydayfeminism.com
  17. Gillihan, S. J. (2019, 26 April). How to recover from gaslighting. WebMD. webmd.com
  18. Coburn, J. (2019, 4 April). How to heal after the emotional abuse of gaslighting. The Mighty. themighty.com

Talk to someone.

You don’t have to make sense of it alone.

Whether in the moment or later, when you feel ready, talk to someone who is compassionate and has your best interests at heart.